RESUMO
Erythema multiforme is a skin disorder characterised by target epithelial eruption, which is mainly caused by infection or drugs. In this case, we report an erythema multiforme like reaction caused by contact dermatitis against wood, especially santos rosewood. During the hospitalisation, we performed a patch test with lumber used in the patient's workplace, and recognised a positive response to multiple woods and a simultaneous recurring eruption (flare up) outside of the test site. The findings from this case of contact dermatitis caused by frequently used industrial wood type is important for the management of occupational environments. A review of the literature on erythema multiforme like reaction due to contact dermatitis, including past case reports, has also been provided.
Assuntos
Eritema Multiforme/etiologia , Doenças Profissionais/etiologia , Madeira/efeitos adversos , Administração Cutânea , Adulto , Clobetasol/administração & dosagem , Dermatite Alérgica de Contato , Eritema Multiforme/diagnóstico , Eritema Multiforme/tratamento farmacológico , Fabaceae/efeitos adversos , Humanos , Masculino , Doenças Profissionais/diagnóstico , Doenças Profissionais/tratamento farmacológico , Testes do Emplastro , Taxaceae/efeitos adversosRESUMO
A 63-year-old female patient with recent diagnosis of hepatitis C and cirrhosis and no other comorbidities, on no medications, was found to have Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma and began systemic therapy with sorafenib 400mg twice daily. Five days after starting treatment, the patient went to an emergency department with pruritic, target-shaped, erythematous papules compatible with erythema multiforme, painful oral aphthous ulcers, and fever. Sorafenib was suspended and the patient underwent oral corticosteroid treatment for 5 days, showing significant improvement of the lesions. One month after discharge, the patient was reassessed at an outpatient clinic. As she was asymptomatic and had no skin lesions, sorafenib was resumed at a lower dose (200mg daily). Three hours after ingesting a single dose of sorafenib, the patient experienced chills, fever, rash, angioedema and stridor. She immediately sought the emergency department and was diagnosed with anaphylaxis. The patient received intravenous corticosteroid therapy, which improved her respiratory and cutaneous symptoms in 72h. Sorafenib was permanently suspended, and regorafenib could not be prescribed as second-line therapy. This is the first description of anaphylaxis to sorafenib.
Assuntos
Anafilaxia/induzido quimicamente , Eritema Multiforme/induzido quimicamente , Prednisona/uso terapêutico , Sorafenibe/efeitos adversos , Anafilaxia/tratamento farmacológico , Antineoplásicos/efeitos adversos , Antineoplásicos/uso terapêutico , Carcinoma Hepatocelular/complicações , Carcinoma Hepatocelular/tratamento farmacológico , Eritema Multiforme/tratamento farmacológico , Feminino , Glucocorticoides/uso terapêutico , Humanos , Cirrose Hepática/complicações , Neoplasias Hepáticas/complicações , Neoplasias Hepáticas/tratamento farmacológico , Pessoa de Meia-Idade , Sorafenibe/uso terapêuticoAssuntos
Alpinia/efeitos adversos , Eritema Multiforme/etiologia , Herpes Simples/complicações , Ayurveda , Preparações de Plantas/efeitos adversos , Aciclovir/administração & dosagem , Adolescente , Antivirais/administração & dosagem , Eritema Multiforme/tratamento farmacológico , Humanos , Lábio/efeitos dos fármacos , Masculino , Úlcera/etiologiaRESUMO
Erythema multiforme (EM) is a known side effect of sorafenib therapy in cancer patients; at onset, the causative medication should be permanently discontinued. Here we report two cases of hepatocellular carcinoma (HCC) that developed sorafenib-induced EM. In both cases, retreatment with sorafenib combined with steroid therapy achieved effective tumor control without EM recurrence. The first patient was a 72-year-old woman who showed a dramatic response to sorafenib retreatment, with complete remission after 8 months of therapy. There was no rash recurrence after the steroid dose was gradually tapered and stopped. The second patient was a 69-year-old man who responded to sorafenib and exhibited stable disease, with no recurrence of the rash after the steroid dose was tapered. However, mild hand-foot syndrome persisted throughout sorafenib therapy. Although sorafenib should be discontinued if EM occurs, if there is no suitable alternative treatment, retreatment may be considered with steroid cover in patients with unresectable HCC.
Assuntos
Antineoplásicos/efeitos adversos , Carcinoma Hepatocelular/tratamento farmacológico , Eritema Multiforme/induzido quimicamente , Eritema Multiforme/tratamento farmacológico , Neoplasias Hepáticas/tratamento farmacológico , Niacinamida/análogos & derivados , Compostos de Fenilureia/efeitos adversos , Prednisolona/administração & dosagem , Idoso , Antineoplásicos/administração & dosagem , Carcinoma Hepatocelular/complicações , Feminino , Humanos , Neoplasias Hepáticas/complicações , Masculino , Niacinamida/administração & dosagem , Niacinamida/efeitos adversos , Compostos de Fenilureia/administração & dosagem , SorafenibeRESUMO
OBJECTIVE: To search for an effective therapy for cold erythema multiforme in ham. METHODS: One hundred and eighty cases with cold erythema multiforme in ham were randomly divided into a Santong group (n=90) and a western medicine group (n=90). The Santong group was treated by He's Santong needling methods and Huantiao (GB 30), Fengshi (GB 31), Zusanli (ST 36), etc. were selected. The western medicine group was treated by oral administration of Cinnarizine, Cyproheptadine and Vitamin E. Two weeks later, their therapeutic effects were observed. RESULTS: The cured rate was 68.9% and the recurrence rate was 11.3% in the Santong group, and 33.3% and 53.3% in the western medicine group, with significant differences in the cured rate and the recurrence rate between the two groups (both P<0.01). CONCLUSION: He's Santong needling methods can increase the cured rate and reduce the recurrence rate of cold erythema multiforme in ham.
Assuntos
Terapia por Acupuntura , Eritema Multiforme/terapia , Adolescente , Adulto , Cinarizina/uso terapêutico , Ciproeptadina/uso terapêutico , Eritema Multiforme/tratamento farmacológico , Feminino , Antagonistas dos Receptores Histamínicos H1/uso terapêutico , Humanos , Masculino , Resultado do Tratamento , Adulto JovemRESUMO
From a clinician's point of view, diseases of the immune system are broadly grouped into the following categories: I. Immunodeficiency disorders II.Autoimmune diseases III. Hypersensitivity reactions (AU)